Innovaderm Research Inc.
Jake C. serves as the Director of Financial Planning and Analysis at Indero (formerly Innovaderm) since November 2023, bringing extensive experience in FP&A, corporate finance, and strategic financial modeling. Prior roles include Senior Manager of Financial Planning & Analysis at Staffbase, focusing on investor relations and budgeting, and Manager of Financial Planning & Analysis at Achievers, where responsibilities included long-term financial modeling and external investor relations. Previous positions feature roles at Anthem Entertainment Group and BGIS, emphasizing FP&A reporting and support for acquisition activities. Jake's career began as a Financial Analyst at Amphenol, following internships in project control and marketing analysis. Educational credentials include CFA and CPA designations and a Bachelor of Arts in Economics from the University of Waterloo.
This person is not in any teams
This person is not in any offices
Innovaderm Research Inc.
1 followers
As a CRO (Clinical Research Organization) specialized in dermatology, we provide scientific guidance, accurate results and customer satisfaction. Our unique service offering combines specialized Contract Research Services, knowledge of dermatology sites in North America and Europe reach and the extended capabilities of a large clinical research site. The design and conduct of Phase 1 to Phase IV studies in Dermatology is our core expertise. Our specialized services include: • Study Design and Protocol Development • Submission to Regulatory Agencies and Central Ethics Committees • Regulatory Consulting • Trial Master Files Management • Project Management • Investigator / Site Selection • Patient Recruitment • Clinical Monitoring • Medical Monitoring • Pharmacovigilance • Data Management • Biostatistical Analysis • Clinical Study Report • Medical Writing / Publication Since 2000, Innovaderm has built a strong reputation for the quality of its research and the care offered to its study participants, its clients and its sites, often exceeding our client’s timeline expectations.